$1B+ Class Action Settlements — Knowledge Baseline

Generated: May 15, 2026 Purpose: Seed background knowledge for the daily-briefing topic project dir tracking the U.S. mega-settlement docket — securities, antitrust, product liability, data breach, and the new AI copyright frontier. Audience: plaintiff-side mega-class firms, defendant-side mega-class defense, settlement administrators, litigation funders, and corporate GCs at frequent-defendant industries.

Active Mega-Settlements (current payment cycles)

Blue Cross Blue Shield Subscriber Antitrust ($2.67B)

The canonical active mega-payout cycle as of mid-May 2026. In re Blue Cross Blue Shield Antitrust Litigation (MDL 2406, N.D. Ala.) before Judge R. David Proctor. Originally filed in 2013 against the 30+ independent BCBS Plans alleging they violated Sherman Act by carving the country into exclusive "Service Areas" and agreeing not to compete nationally. Settlement administrator JND Legal Administration began issuing payments on or about May 11, 2026 to approximately 7.8 million approved claimants. Of the $2.67B gross fund, roughly $1.9B is net distributable after fees and admin costs. Distribution structure: pro rata, with a tiered framework — claims under the $5 de minimis threshold receive no initial-round payment; claims between $5 and $200 receive full payment in round one; claims at or above $200 receive 90% in round one with 10% held in reserve for a true-up second distribution. Payment methods include check, PayPal, Venmo, and electronic debit card.

Bartz v. Anthropic PBC (N.D. Cal.), Judge Araceli Martínez-Olguín. Largest copyright settlement in U.S. history and the first major U.S. generative-AI training-data class settlement. Fairness hearing held May 14, 2026 (yesterday relative to today's briefing date), under submission. Anthropic won on fair use at summary judgment but agreed to settle the piracy-acquisition piece (LibGen/Z-Library shadow-library training corpus) for $1.5B in August/September 2025. Settlement covers approximately 500,000 works; 91.3% claims rate (440,490 works claimed) by the deadline — exceptionally high by class-action benchmarks. Per-work compensation approximately $3,000. Unsealed objections center on: exclusion of foreign/non-US-registered works; systematic favoring of publishers over authors in allocation; misleading or coercive class notice; inadequate quantum relative to damages; class counsel conflict-of-interest concerns; and undercounting of copyright registrations. The Authors Alliance, Authors Guild, and Publishers Weekly have been most active in tracking. Cross-reference Tab 02 (LLM/copyright) for related Anthropic and broader AI copyright docket.

Purdue / Sackler Opioid Settlement ($7.4B)

In re Purdue Pharma L.P. (Bankr. S.D.N.Y.) — confirmed in 2025 by Judge Sean Lane after the original $6B plan was rejected by the Supreme Court in Harrington v. Purdue Pharma (2024) for impermissibly granting third-party releases. The reworked plan: Sacklers pay up to $6.5B over 15 years; Purdue contributes $900M from estate. Plan went effective May 1, 2026 (per Michigan AG). Initial tranche: ~$1.5B from Sacklers plus ~$900M from Purdue paid at effectiveness. Subsequent Sackler tranches: ~$500M in May 2027, $500M in May 2028, $400M in May 2029. All 55 AGs joined. Sacklers permanently banned from U.S. opioid manufacture/sale. ProPublica and victim advocates flagged that many individual victims will be shut out under the allocation framework.

Roundup / Bayer ($7.25B class component)

In re Roundup Products Liability Litigation — Monsanto announced on February 17, 2026 a proposed nationwide Rule 23(b)(3) class settlement for current and future NHL claimants. Up to $7.25B over 21 years with declining capped annual payments. Preliminary approval granted March 2026; final approval fairness hearing July 9, 2026. Per-claimant ceiling of ~$165,000 keyed to exposure, disease grade, and age. The class settlement is layered on top of the ongoing MDL/state-court inventory; Bayer has paid roughly $11B cumulatively in Roundup litigation, with September 30, 2025 provisions totaling €11.8B (€9.6B glyphosate-specific). The deal is drawing critic objection on the lawyer-fee-to-class-recovery ratio.

Pending Mega-Settlements (preliminary approval / fairness hearing pending)

Securities-Fraud Mega-Cycle 2025–2026

Cornerstone Research's 2025 review found 74 securities class-action settlements totaling $3.0B in 2025, with the median settlement amount reaching a near-three-decade high of $17.3M. ISS SCAS counts 115 court-approved monetary settlements in 2025 (down 15% year-over-year), with eight "mega settlements" ($100M+) totaling more than $1.6B. The two new entries to the all-time Top 100 were Alibaba ($433.5M) and General Electric ($362.5M).

Notable 2025 disbursements: Kraft Heinz $450M (May 2025 payout), Alphabet $350M (July 2025 payout). Pipeline for 2026: Didi Global $740M, Rivian $250M, Celgene $239M, FIS $210M.

Lead-counsel landscape on the all-time Top 100 (ISS SCAS, 2025 edition): - Bernstein Litowitz Berger & Grossmann — 37 cases as lead or co-lead, aggregate $27.3B; three of the top ten. - Robbins Geller Rudman & Dowd — 24 cases, aggregate $20.1B; the only firm with multiple $1B+ recoveries as sole lead counsel (Enron $7.2B; Household International $1.575B; Valeant; American Realty). 2025 plaintiffs'-firm-of-the-year by recovery total, with $916.3M reported.

Cornerstone and NERA both publish annual reviews (Cornerstone's "Securities Class Action Settlements" and NERA's "Recent Trends in Securities Class Action Litigation"). Stanford Securities Class Action Clearinghouse (SCAC) remains the canonical filings/settlement database.

Antitrust Mega-Cycle

Product-Liability Mega-Cycle

Data-Breach Mega-Cycle

CFO Dive / Duane Morris 2025 Annual Roundup

Duane Morris' 2026 Class Action Review (mid-January 2026 release) is the canonical industry roundup: - Top 10 settlements aggregated to $79B in 2025 (up from $42B in 2024 — itself the third consecutive year above $40B). - 13,000+ federal class actions filed in 2025 = 36 per day. - 68% of class certification motions granted in 2025 (up from 63% in 2024). - Generative AI and crypto added as standalone categories for the first time. - The $79B aggregate is heavily weighted by Visa/Mastercard (~$38B), BCBS Subscriber ($2.67B) and Provider ($2.8B), Purdue/Sackler ($7.4B), Roundup ($7.25B), and Bartz ($1.5B). Defense-side commentary frames the number as inflated by deal-valuation methodology (Visa/Mastercard interchange relief valued on projected forgone fees over many years).

Class-Certification Doctrine in Mega-Cases

Objector Practice

Less than 1% of class members object in a typical class action, but the appellate impact is outsized. The career-objector ecosystem (sometimes pejoratively "professional objectors") consists of repeat-player counsel who file objections — sometimes substantively, sometimes as leverage for fee shifts. Rule 23(e)(5)(B), added in 2018, requires court approval for any consideration paid to withdraw an objection, designed to suppress "objector blackmail."

Recent appellate-court scrutiny: - Eighth Circuit "windfall" reversal (2024) — Reversed an $80M fee award in a "megafund" case that had barely begun before settling. Signal that clear-sailing and reverter provisions face heightened scrutiny. - Delaware Chancery fee-award debate — Harvard Law's Corporate Governance Forum published a 2025 dataset urging more fee-award discipline post-Tornetta v. Musk. - Career objector profile — Lopatka/Judicial Studies Duke paper and the NALFA-cited St. John's Law Review study are the standard secondary sources.

For mega-class fairness hearings (BCBS Subscriber, Bartz, Roundup), counsel should anticipate Rule 23(e)(5) objections on: (a) class-counsel fee multiplier; (b) plan of allocation; (c) class-representative service awards; (d) clear-sailing or reverter; (e) cy pres designations and recipient ties to counsel.

Distribution Mechanics at Scale

Settlement-Administrator Landscape

Key Actors

Plaintiffs' firms (mega-class lead/co-lead)

Defense firms (mega-class defense)

Wachtell (securities/antitrust); Sullivan & Cromwell (Visa/Mastercard-side); Gibson Dunn (class-cert defense leader, Boutrous shop); Kirkland (bankruptcy overlap — Purdue, J&J talc); Paul Weiss (Petrobras-side $1.8B FCPA); Skadden; Cravath; Latham & Watkins (Anthropic counsel); Williams & Connolly (product-liability trial defense).

Academic scholars

John C. Coffee Jr. (Columbia) — Securities class action deterrence and reform. Samuel Issacharoff (NYU) — Aggregate litigation, class-action governance (casebook with Miller). Robert Klonoff (Lewis & Clark) — Class action treatise. Linda Mullenix (UT Austin) — Mass tort. William Rubenstein (Harvard) — Newberg on Class Actions. Brian Fitzpatrick (Vanderbilt) — Empirical data; Class Action Playbook.

Consulting / economic

Cornerstone Research (annual securities settlement review); NERA Economic Consulting ("Recent Trends"); ISS SCAS (Top 100); Stanford SCAC (filings/settlements DB).

  1. Claims-rate signaling for fairness — How low can a claims rate go before Rule 23(e)(2)(C)(ii) fairness is impaired? Bartz at 91.3% is a high-water benchmark; many consumer mega-classes settle below 5%.
  2. Objector standing on appeal — Devlin v. Scardelletti (2002) gives unnamed class members standing to appeal final approval if they objected at the fairness hearing. Career-objector incentives shift downstream of Rule 23(e)(5)(B).
  3. Carry-over residuals and cy pres — When can residuals be redistributed to a smaller subset of claimants vs. forced to cy pres? Increasing judicial preference for second-tier pro rata over cy pres-only solutions.
  4. Class definition in mega-cases — Bartz's exclusion of non-U.S.-registered works has surfaced live objections that may foreshadow circuit precedent on extraterritorial class scope post-Morrison v. National Australia Bank (2010).
  5. Third-party non-debtor releases — Post-Harrington v. Purdue Pharma (2024), bankruptcy as a mass-tort resolution vehicle requires substantive consideration from the released party and consent from claimants. Talc III's rejection cited similar reasoning.
  6. Uninjured class members and predominance — Circuit split between 9th (Olean), D.C. (Rail Freight), and 1st (Asacol). Awaiting SCOTUS cert vehicle.
  7. Article III standing for absent class members — TransUnion v. Ramirez (2021) requires concrete injury for each class member to recover damages; impact on data-breach and statutory-damages classes is still being worked out.
  8. AI training-data class scope — Bartz settled before the class-cert opinion on works owned by non-claimants would have to issue. The legal question (how to certify a copyright class spanning hundreds of thousands of works with heterogeneous chain-of-title) is unresolved.

Source Landscape

Watchlist (next 60 days)

  1. Bartz v. Anthropic — Final approval order from Judge Martínez-Olguín following May 14 fairness hearing. Cross-reference Tab 02. Watch for fee-multiplier ruling, objector-standing rulings on the foreign-works exclusion, and any conditions on the distribution plan.
  2. BCBS Subscriber payments — Monitor JND's roll-out pace; second-distribution timing (10% holdback) is the next milestone.
  3. Roundup class — July 9, 2026 fairness hearing. Watch for objector turnout on the lawyer-fee ratio. Bayer's Q2 earnings (early August) will quantify accrual changes.
  4. Visa/Mastercard interchange revised settlement — Briefing schedule on objections; merchant-coalition motion practice through summer.
  5. J&J talc tort track — With bankruptcy exit now closed (no appeal), watch for the first MDL bellwether trials post-rejection.
  6. CFO Dive / Duane Morris mid-year update — Typically released early July. Watch for restated 2026-YTD aggregate and category mix.
  7. ISS SCAS Top-100 updates — Quarterly refresh; Didi Global $740M and Celgene $239M among additions.
  8. 9th Circuit / D.C. Circuit uninjured-class-members docket — Watch for any SCOTUS cert grant in the Olean / Rail Freight / Asacol circuit split.
  9. Generic-drugs MDL 2724 — Whether Teva/Mylan-Viatris settle ahead of trial readiness.
  10. Anthropic-style follow-on AI cases — Disney v. Midjourney class-cert briefing; OpenAI/Microsoft S.D.N.Y. consolidated track scheduling.
  11. Tesla securities class period close-out — Lead-plaintiff motions and consolidation order shape the negotiation table.
  12. Purdue/Sackler implementation — Watch first individual victim distributions under the new framework; ProPublica and state AGs will document gaps.

End of background.md — This document is the working knowledge baseline for daily-briefing project dir billion-dollar-class-actions/. Update upon material developments at Tab 02 cross-references, BCBS distribution milestones, or major mega-class fairness rulings.